274 related articles for article (PubMed ID: 32403277)
1. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
2. Computer-Aided Search for 5-Arylideneimidazolone Anticancer Agents Able To Overcome ABCB1-Based Multidrug Resistance.
Kaczor A; Szemerédi N; Kucwaj-Brysz K; Dąbrowska M; Starek M; Latacz G; Spengler G; Handzlik J
ChemMedChem; 2021 Aug; 16(15):2386-2401. PubMed ID: 33929088
[TBL] [Abstract][Full Text] [Related]
3. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
Wang J; Yang DH; Yang Y; Wang JQ; Cai CY; Lei ZN; Teng QX; Wu ZX; Zhao L; Chen ZS
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092870
[TBL] [Abstract][Full Text] [Related]
5. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
7. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
8. N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H
Szczepańska K; Kincses A; Vincze K; Szymańska E; Latacz G; Kuder KJ; Stark H; Spengler G; Handzlik J; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2020 Nov; 30(22):127522. PubMed ID: 32871268
[TBL] [Abstract][Full Text] [Related]
9. New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
Čižmáriková M; Takáč P; Spengler G; Kincses A; Nové M; Vilková M; Mojžiš J
Anticancer Res; 2019 Dec; 39(12):6499-6505. PubMed ID: 31810914
[TBL] [Abstract][Full Text] [Related]
10. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
[TBL] [Abstract][Full Text] [Related]
11.
Bourichi S; Misbahi H; Rodi YK; Chahdi FO; Essassi EM; Szabó S; Szalontai B; Gajdács M; Molnár J; Spengler G
Anticancer Res; 2018 Jul; 38(7):3999-4003. PubMed ID: 29970523
[TBL] [Abstract][Full Text] [Related]
12. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
Żesławska E; Kucwaj-Brysz K; Kincses A; Spengler G; Szymańska E; Czopek A; Marć MA; Kaczor A; Nitek W; Domínguez-Álvarez E; Latacz G; Kieć-Kononowicz K; Handzlik J
Bioorg Chem; 2021 Apr; 109():104735. PubMed ID: 33640632
[TBL] [Abstract][Full Text] [Related]
13. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
Spengler G; Kincses A; Rácz B; Varga B; Watanabe G; Saijo R; Sekiya H; Tamai E; Maki J; Molnár J; Kawase M
Anticancer Res; 2018 Nov; 38(11):6181-6187. PubMed ID: 30396935
[TBL] [Abstract][Full Text] [Related]
14. Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells.
Abdelhafiz AHA; Serya RAT; Lasheen DS; Wang N; Sobeh M; Wink M; Abouzid KAM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2710-2724. PubMed ID: 36168121
[TBL] [Abstract][Full Text] [Related]
15. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
16. Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MJ
Phytomedicine; 2016 Aug; 23(9):968-78. PubMed ID: 27387405
[TBL] [Abstract][Full Text] [Related]
17. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
Liu DL; Li YJ; Yao N; Xu J; Chen ZS; Yiu A; Zhang CX; Ye WC; Zhang DM
Eur J Pharmacol; 2014 Jun; 733():34-44. PubMed ID: 24704556
[TBL] [Abstract][Full Text] [Related]
18. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
[TBL] [Abstract][Full Text] [Related]
19. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
20. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
